AbbVie Inc (ABBV)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 73.61% | 76.85% | 72.49% | 68.40% | 68.52% | 65.76% | 68.91% | 69.43% | 70.00% | 69.62% | 70.48% | 69.53% | 68.96% | 67.72% | 65.62% | 64.82% | 66.41% | 68.74% | 73.56% | 77.43% |
| Operating profit margin | 16.22% | 24.89% | 22.31% | 23.50% | 23.49% | 27.32% | 31.03% | 28.49% | 31.21% | 30.59% | 30.33% | 32.68% | 31.89% | 30.09% | 28.95% | 23.63% | 24.81% | 28.45% | 30.17% | 39.86% |
| Pretax margin | 6.60% | 12.96% | 12.85% | 13.84% | 11.51% | 14.51% | 18.65% | 15.90% | 23.21% | 25.57% | 24.54% | 24.77% | 23.11% | 13.07% | 11.21% | 8.30% | 7.42% | 19.63% | 20.65% | 26.37% |
| Net profit margin | 7.59% | 9.22% | 9.71% | 11.02% | 8.95% | 11.81% | 15.50% | 13.37% | 20.39% | 23.19% | 22.04% | 22.00% | 20.54% | 13.66% | 12.40% | 10.28% | 10.08% | 18.16% | 19.20% | 24.77% |
AbbVie Inc's profitability ratios demonstrate fluctuations over the years. The Gross Profit Margin, which indicates the percentage of revenue remaining after accounting for the cost of goods sold, ranged from a high of 77.43% in March 2020 to a low of 65.76% in September 2023, showing some volatility before increasing to 73.61% by December 2024.
The Operating Profit Margin, representing the company's efficiency in controlling operating expenses, declined from 39.86% in March 2020 to 16.22% in December 2024. This ratio experienced significant variability over the years, indicating fluctuations in operating efficiency.
The Pretax Margin, reflecting the company's profitability after all expenses are considered but before taxes are deducted, was the most volatile, ranging from 26.37% in March 2020 to 6.60% in December 2024. The trend in this ratio suggests varying levels of income generation before tax impact.
The Net Profit Margin, which shows the percentage of revenue that translates into income for the company after all expenses and taxes have been deducted, fluctuated from 24.77% in March 2020 to 7.59% in December 2024. This ratio indicates the company's overall ability to generate profit from its operations.
Overall, AbbVie Inc's profitability ratios demonstrate fluctuations, with each ratio showing different trends and levels of volatility over the years.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 6.76% | 9.64% | 8.65% | 8.59% | 9.47% | 11.06% | 12.84% | 12.02% | 13.05% | 12.52% | 12.15% | 12.94% | 12.23% | 11.15% | 10.51% | 7.88% | 7.55% | 7.73% | 7.31% | 14.89% |
| Return on assets (ROA) | 3.17% | 3.57% | 3.76% | 4.03% | 3.61% | 4.78% | 6.42% | 5.64% | 8.53% | 9.49% | 8.83% | 8.71% | 7.88% | 5.06% | 4.50% | 3.43% | 3.07% | 4.93% | 4.65% | 9.25% |
| Return on total capital | 293.77% | 263.33% | 228.73% | 192.91% | 150.92% | 142.13% | 153.47% | 154.75% | 128.01% | 142.39% | 154.60% | 132.94% | 135.59% | 150.63% | 151.55% | 120.46% | 120.06% | 83.01% | 87.18% | — |
| Return on equity (ROE) | 128.66% | 84.91% | 78.77% | 74.85% | 46.94% | 53.86% | 67.50% | 57.14% | 68.60% | 83.83% | 86.24% | 76.64% | 74.91% | 55.60% | 53.01% | 37.63% | 35.30% | 48.34% | 47.30% | — |
AbbVie Inc's profitability ratios exhibit variations over the period under consideration. The Operating return on assets (Operating ROA) started at 14.89% in March 2020 and fluctuated, reaching a peak of 13.05% in December 2022 before declining to 6.76% in December 2024. This ratio signifies the company's operational efficiency in generating profits from its assets.
The Return on assets (ROA) ratio shows a decreasing trend from 9.25% in March 2020 to 3.17% in December 2024, indicating a decline in the company's ability to generate profit relative to its total assets.
The Return on total capital ratio demonstrates an inconsistent pattern, starting from a missing value in March 2020 and reaching a peak of 293.77% in December 2024. This ratio reflects how efficiently the company utilizes its total capital to generate profits.
Lastly, the Return on equity (ROE) ratio showcases a mix of uptrends and downtrends, starting from 47.30% in June 2020, peaking at 128.66% in December 2024. This ratio highlights the company's ability to generate profits relative to shareholders' equity.
Overall, AbbVie Inc's profitability ratios depict fluctuations in its operational performance and financial efficiency over the analyzed period.